ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EDEN Eden Research Plc

4.25
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.25 4.00 4.50 4.25 4.25 4.25 33,806 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -10.12 22.67M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.25p. Over the last year, Eden Research shares have traded in a share price range of 3.20p to 12.00p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £22.67 million. Eden Research has a price to earnings ratio (PE ratio) of -10.12.

Eden Research Share Discussion Threads

Showing 3276 to 3299 of 17875 messages
Chat Pages: Latest  139  138  137  136  135  134  133  132  131  130  129  128  Older
DateSubjectAuthorDiscuss
14/11/2017
15:54
Superpower self poisoning accelerator incident news .
supersonico
13/11/2017
21:07
Fungicide resistance news

Resistance to the QoI (Strobilurin) Fungicides in Grape Powdery Mildew on the Central Coast

supersonico
13/11/2017
18:39
It appears on the Eden website the it is "delivered by Investis"
investingisatrickygame
12/11/2017
13:47
I may well be barking up a non existent tree or only noticed something recently that has been in place for a while and all of a sudden I've seen it and thinking it's new attributed it to a new move where in fact it's been there all along or for a while at least.

I noticed that the Eden report with the two new names was hosted by Investis in a different way to the last report.





I then wondered if this was part of a new episode in promoting and rebranding the company along with Powerscourt. I then got all excited as Investis have big clients in the same way Powerscourt do and imagined Eden getting plenty of attention and perhaps even some new investors which might tickle the share price


All will be revealed no doubt.

supersonico
12/11/2017
13:04
I'm sorry, I still don't understand.

You said 'Eden updated report hosted by Investis' which I took to mean that Investis had published an updated Eden report, but I can't see the same.

What am I not understanding?

investingisatrickygame
11/11/2017
23:49
If green thumbs UP are a guide to it's relevance then your not alone .
supersonico
11/11/2017
23:31
I can't see the relevance of investis in your link with regards to Eden.
investingisatrickygame
11/11/2017
13:35
Eden updated report hosted by Investis.



Telling the story behind the numbers
We’ll help you tell your investor story so you can demonstrate your true value to investors and analysts everywhere.
Whether it’s connecting through a webcast, utilizing your annual report content or providing your latest share price, your investor audiences will always get the story behind the numbers.
Communicating your investment case.


Like the Powerscourt move this company play in the big league with global giants as clients (Rolls Royce /Ford/ Unilever/ BP/ AngloAmerican/ Alibaba/ General Electric )..
Certainly looks like there is a push towards raising awareness among investors and promoting the company.

supersonico
11/11/2017
10:54
UPdated company presentation.



with some new roles P5 (or people I had not noticed before now)

James Clovis @@.Business development./





Both James Kennedy and Clovis @ Gemini Agriculture Ltd

James Kennedy@@Product & project management.

I would like to introduce our company Gemini Agriculture Ltd
Myself and James Kennedy (previously of DuPont & Certis UK) have embarked on an exciting new venture offering sales and marketing expertise, alongside a range of associated customer benefits, providing a route to market for agrochemical products in the UK, Europe and beyond.
We have partnered with Whyte’s Chemical’s, a manufacturer with years of successful production experience in the agrochemical sector, giving us access to local production in the UK and allowing us to establish a registration base with which we can deliver a strong performance in customer satisfaction.
Our aim is simple; to never compromise on quality and to deliver every load on time and in full, at a very competitive price.
We want to work in partnership with our customers and suppliers, transparently and honestly offering a range of agrochemicals, micro nutrients & bio pesticides. From sales support for formulated and packed products to assisting in trials, business cases & data for Annex 3 preparations, we have the skills, experience and knowledge to help support and grow your business.
Please contact us to discuss your business-related requirements and how we can support you in achieving your current and future company objectives.







...........................................................................................................................................................

supersonico
04/11/2017
14:10
Pesticide News;

File under ; How to destroy your customer base ..doh.
or Where did all our customers Go?
or The Autistic Shopper..a growth market ?
or Anyone Seen my Gut Flora?






Enhanced understanding of the microbiome is helping medicine



Nematicide seed treatment market .


hTps://inhabitat.com/groundbreaking-study-confirms-neonicotinoids-are-toxic-to-songbirds/

..........................

supersonico
03/11/2017
10:44
Investing,

Re Lynette Zang..

I'm not really making a point just drawing attention to her observations.

I listen a fair bit to her and she seems perceptive, switched on and genuine.

If there is a point I think its own precious metals ..fiat money reset beckons

supersonico
03/11/2017
08:47
Supersonic,

What is your point?

investingisatrickygame
02/11/2017
18:08
Insider Trading Pattern shift alert

Lynette Zang.




Global QE has peaked.

supersonico
02/11/2017
09:43
Sumitomo sponsored. (platinum) is that like the Jack of Clubs in Whist?



.................................
Parking

supersonico
02/11/2017
08:45
Re MBI, old footage now, but at least she is on the front foot. Interesting that her product is organic.
investingisatrickygame
01/11/2017
20:58
11min..discusses 'busy market place' for Fungicide and Nematicide and unmet needs in market they are targeting..same opportunities EDEN seeking to exploit.

18.30 Talks about current investment in agriculture.

supersonico
01/11/2017
17:23
MBI CEO interview









Great spokes woman for company and message / strategies relevant to Eden market, many parallels .

Opportunity for encapsulation technology ..hook up??

Perhaps the recent Agrow awards offered an opportunity for SS to hobnob with fellow panellist Pamela G. Marrone,





Best R&D Pipeline
Winner: Dow AgroSciences
HIGHLY COMMENDED: Marrone Bio Innovations

supersonico
01/11/2017
16:52
Ooops, I was looking at their website - where I lazily found nothing in their reports and on the ADVFN financial page.

Thanks supersonico. You have found an interesting company.

attyg
01/11/2017
16:44
Marrone Bio Innovations, Inc. Reports Second Quarter 2017 Financial Results
supersonico
01/11/2017
16:19
Company ticker is

MBII

Insert into ADVFN and the financials show a market cap of $30m - no sales, etc.

Then we have Eden, with mkt cap of £20m and the vast array of opportunities and agreements etc.

Oh well

attyg
01/11/2017
14:42
Novel Biofungicide Approved for Grapes, Leafy Greens
supersonico
31/10/2017
17:02
Adding to that commentary, Eden share price is down 3.7% today on volume of around 400,000 shares versus shares in issue of 207 million. So one fifth of one per cent of the shares in issue have been traded.

That indicates to me that no one has a reason to buy and very few wish to sell at such a low level. The result is no motivation in the stock. The longer that continues the harder it is to create and with any decent upward spike a raft of sales will occur with investors feeling relieved that they got out the right side of break even.

investingisatrickygame
31/10/2017
16:52
I think the reality though is that there are currently two "markets". Private investors who are risk happy or risk adverse and then the other market is the "City", the institutional investors.

The latter doesn't appear to be giving Eden much credit and maybe they will AttyG when Eden hits + P and L and good cashflows for a full year. So I would argue, that half of the market is not listening or has listened and needs more convincing.

If the above is a correct assumption then the market for the foreseeable future is private investors. It is this market that needs to understand the current value and achievements of Eden so that they can price the shares correctly. To do this, they need Eden to educate them to enable them to price the shares correctly. Without doing so there is no market in Eden's shares and the stock becomes both illiquid and near static in price. The slightest transaction creates unrealistic movement in the share price. I would argue that this is exactly where Eden is right now and this cannot be good for Eden, its City facing image and its shareholders.

The only people with the power to create change is the Eden BoD and they need to recognise in themselves both the power and the responsibility they have to give the shares a chance of being priced correctly. Relying on the City at this stage is likely futile and it is typical behaviour of AIM Company representatives who prefer to be City facing rather than market facing. I'm sure the NOMAD's have a role in this too. Markets are fluid and as such, the target audience changes over time with maturity and commercial success.

Companies need to recognise and accept that what was the way to do things is not necessarily the same now with the power of business and social media and with more individuals taking responsibility for their capital's growth, both private monies and SIPP funds too.

Companies that recognise and accept this do, in my opinion, have a greater chance of share price success with the inevitable move into market two, the institutions. There are certainly examples to support this.

investingisatrickygame
31/10/2017
16:10
Agreed AttyG
Certainly a good price to fill ones welly's.

supersonico
Chat Pages: Latest  139  138  137  136  135  134  133  132  131  130  129  128  Older

Your Recent History

Delayed Upgrade Clock